Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)
Themistocles Dassopoulos(Cedars-Sinai Medical Center), Hillary Steinhart(Mount Sinai Hospital), Judy H. Cho(Cedars-Sinai Medical Center), Geoffrey C. Nguyen(Johns Hopkins Medicine), Federico Gregory(University of Puerto Rico, Medical Sciences Campus), Steven R. Brant(Rutgers, The State University of New Jersey), Richard H. Duerr(University of Pittsburgh), Kent D. Taylor(Cedars-Sinai Medical Center), Alain Bitton(McGill University Health Centre), Denis Franchimont(McGill University Health Centre), Abdul Elkadri(Medical College of Wisconsin), Sunanda V. Kane(Mayo Clinic), Laura Harrell(University of Chicago), Esther A. Torres(University of Puerto Rico, Medical Sciences Campus), L. Philip Schumm(Chicago Department of Public Health), John D. Rioux(Institute for Molecular Medicine Finland), Benjamin Siemanowski(University of Pittsburgh Medical Center), Anne M. Griffiths(University of Toronto), Yahong Wu(University of Chicago), Jean-Paul Achkar(Cleveland Clinic), Mark S. Silverberg(Sinai Health System), Miguel Regueiro(Cleveland Clinic), Gillian Bromfield(University of Chicago)
Cited by 45
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k